China

Top 97 largest Chinese Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from China by market capitalization with links to their reference stock.

China Biotechnology Industry Analysis
Top Chinese Companies China Analysis
World Top Companies World Companies Analysis
⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Top Biotechnology Companies from China as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
91 Brii Biosciences Ltd $161.1 M China Chinese Healthcare Chinese Biotechnology
92 Connect Biopharma Holdings Ltd $140.9 M China Chinese Healthcare Chinese Biotechnology
93 Kintor Pharmaceutical Ltd $122.9 M China Chinese Healthcare Chinese Biotechnology
94 Adagene, Inc. $86.7 M China Chinese Healthcare Chinese Biotechnology
95 Universe Pharmaceuticals, Inc. $2.3 M China Chinese Healthcare Chinese Biotechnology
96 Hard to Treat Diseases, Inc. $109,646 China Chinese Healthcare Chinese Biotechnology
97 China Biologic Products Holdings, Inc. China Chinese Healthcare Chinese Biotechnology

Top Biotechnology Companies from China as of Jan. 01, 2026

91. Brii Biosciences Ltd

Company Profile: Brii Biosciences Ltd
Market Cap (USD): $161.1 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

92. Connect Biopharma Holdings Ltd

Company Profile: Connect Biopharma Holdings Ltd
Market Cap (USD): $140.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

93. Kintor Pharmaceutical Ltd

Company Profile: Kintor Pharmaceutical Ltd
Market Cap (USD): $122.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

94. Adagene, Inc.

Company Profile: Adagene, Inc.
Market Cap (USD): $86.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

95. Universe Pharmaceuticals, Inc.

Company Profile: Universe Pharmaceuticals, Inc.
Market Cap (USD): $2.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

96. Hard to Treat Diseases, Inc.

Company Profile: Hard to Treat Diseases, Inc.
Market Cap (USD): $109,646
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

97. China Biologic Products Holdings, Inc.

Company Profile: China Biologic Products Holdings, Inc.
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

Stay in touch